ID   YCU-MS861
AC   CVCL_8021
SY   YCU MS861
DR   Cosmic; 1136970
DR   Cosmic; 1556183
DR   GEO; GSM1643586
DR   Wikidata; Q54995355
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26754630;
CC   Population: Japanese.
CC   Doubling time: 16.64 hours (PubMed=21362583).
CC   HLA typing: A*24:02,26:01 (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age of donor, HLA typing and STR profile from personal communication of Sano, Daisuke.
CC   Misspelling: KCC MS861; PubMed=21362583.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 13
ST   D21S11: 31
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 10,11
ST   FGA: 22,24
ST   Penta D: 10
ST   Penta E: 5
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
RX   PubMed=18097577; DOI=10.3892/or.19.1.65;
RA   Taguchi T., Tsukuda M., Imagawa-Ishiguro Y., Kato Y., Sano D.;
RT   "Involvement of EGFR in the response of squamous cell carcinoma of the
RT   head and neck cell lines to gefitinib.";
RL   Oncol. Rep. 19:65-71(2008).
//
RX   PubMed=21362583; DOI=10.1016/j.anl.2011.01.018;
RA   Sakakibara A., Tsukuda M., Kondo N., Ishiguro Y., Kimura M.,
RA   Fujita K., Takahashi H., Matsuda H.;
RT   "Examination of the optimal condition on the in vitro sensitivity to
RT   telomelysin in head and neck cancer cell lines.";
RL   Auris Nasus Larynx 38:589-599(2011).
//
RX   PubMed=21631644; DOI=10.1111/j.1349-7006.2011.01999.x;
RA   Kondo N., Tsukuda M., Taguchi T., Nakazaki K., Sakakibara A.,
RA   Takahashi H., Toth G., Nishimura G.;
RT   "Gene status of head and neck squamous cell carcinoma cell lines and
RT   cetuximab-mediated biological activities.";
RL   Cancer Sci. 102:1717-1723(2011).
//
RX   PubMed=26754630; DOI=10.1186/s13046-016-0284-4; PMCID=PMC4709939;
RA   Hyakusoku H., Sano D., Takahashi H., Hatano T., Isono Y., Shimada S.,
RA   Ito Y., Myers J.N., Oridate N.;
RT   "JunB promotes cell invasion, migration and distant metastasis of head
RT   and neck squamous cell carcinoma.";
RL   J. Exp. Clin. Cancer Res. 35:6.1-6.12(2016).
//